from Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas

Shrigley Hall Hotel, Manchester, UK. 28 30 May 2002

Edited by Michael J Brown

This review is part of a collection of working papers first presented at the Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas, held between 28 30 May 2002 at Shrigley Hall Hotel, Manchester, UK. The meeting was sponsored by the Mectizan® Donation Program, Merck & Co., Inc., and GlaxoSmithKline and was kindly hosted by the Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine.